Clinical importance of VEGFC and PD‐L1 co‐expression in lung adenocarcinoma patients

BACKGROUND: Vascular endothelial growth factor C (VEGFC), an activator of lymphangiogenesis, is newly identified as an immunomodulator which can regulate the immune system so that tumor cells more easily escape immune surveillance. Evidence has shown programmed cell death‐ligand 1 (PD‐L1) can also s...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, Tingting, Xia, Junling, Liu, Shaochuan, Wang, Jing, Liu, Hailin, Zhang, Yan, Jia, Yanan, Li, Kai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7180596/
https://www.ncbi.nlm.nih.gov/pubmed/32154654
http://dx.doi.org/10.1111/1759-7714.13354

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7180596/
https://www.ncbi.nlm.nih.gov/pubmed/32154654
http://dx.doi.org/10.1111/1759-7714.13354

Ejemplares similares